CS logo
small CS logo
Portland location

Portland, Oregon, United States
City in Oregon

About Portland location


Portland, Oregon’s largest city, sits on the Columbia and Willamette rivers, in the shadow of snow-capped Mount Hood. It’s known for its parks, bridges and bicycle paths, as well as for its eco-friendliness and its microbreweries and coffeehouses. Iconic Washington Park encompasses sites from the formal Japanese Garden to Oregon Zoo and its railway. The city hosts thriving art, theater and music scenes. ― Google
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Portland location


During the past decade, Portland location conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Portland location" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Portland location


According to Clinical.Site data, the most researched conditions in "Portland location" are "Homozygous Familial Hypercholesterolemia (HoFH)" (2 trials), "AMD" (1 trials), "CNV" (1 trials), "Wet AMD" (1 trials) and "Wet Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Portland location" in a lesser frequency.

Clinical Trials Intervention Types at Portland location


Most popular intervention types in "Portland location" are "Biological" (2 trials), "Drug" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "AAV directed hLDLR gene therapy" (1 trials), "RGX-314" (1 trials), "Ranibizumab (LUCENTIS®)" (1 trials) and "Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Portland location


The vast majority of trials in "Portland location" are 3 trials for "All" genders.

Clinical Trials Status at Portland location


Currently, there are NaN active trials in "Portland location". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Portland location, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Portland location, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".